Tight Glycemic Control of Little Value Post-Pediatric Heart Op Selective serotonin reuptake inhibitors, including citalopram, escitalopram, and amitriptyline, are associated with prolonged corrected ...

Boston, MA - Patients who receive high doses of the antidepressants citalopram or escitalopram could potentially develop QT-interval prolongation, a marker of a slight increased risk for ventricular ...

There were 252 patients with EKG results included for the analysis; they were given concomitant therapy for median 7 days. This article is written live from ID Week 2017 Annual Meeting in San Diego, ...

Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations.

Please provide your email address to receive an email when new articles are posted on . Compared with married people, unmarried people were more likely to have a prolonged QT interval, according to ...

For many years, moderate alcohol intake and its effect on health have been subject to much debate, particularly concerning cardiovascular health. Indeed, light-to-moderate use of alcohol has been ...

Silver Spring, MD - The FDA's Cardiovascular and Renal Drugs Advisory Committee has ruled that the clinical trials conducted by Bayer/GlaxoSmithKline for its erectile dysfunction drug, vardenafil ...

Plausible explanations for differences in the prognostic impact of prolonged QTc interval among the studies are the occurrence of chance, bias and uncontrolled confounding variables. Chance could have ...

The QT interval is the time from the beginning of the QRS complex (ventricular depolarization) to the end of the T wave (ventricular repolarization). The normal QT interval is controversial and ...

Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma Investigation and utilization of molecularly targeted agents has induced a number of drug ...

Results to be Included in BYDUREON TM New Drug Application Resubmission in the Third Quarter of 2011 SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)--Amylin Pharmaceuticals, Inc. (Nasdaq: ...